-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 C/qwI0+OTwAEo8ZnA2p+a/5OUcH2hYOI0L+yQ7dujKuVy853tLhkmVa1Bvwv9XkD
 StMA3fkDeyd+UsCytXj7AA==

<SEC-DOCUMENT>0001144204-06-053950.txt : 20070212
<SEC-HEADER>0001144204-06-053950.hdr.sgml : 20070212
<ACCEPTANCE-DATETIME>20061221170311
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001144204-06-053950
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20061221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ADVANCED BIOTHERAPY INC
		CENTRAL INDEX KEY:			0000791833
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				510402415
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		141 WEST JACKSON BLVD.
		STREET 2:		SUITE 2182
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604
		BUSINESS PHONE:		312-427-1912

	MAIL ADDRESS:	
		STREET 1:		141 WEST JACKSON BLVD.
		STREET 2:		SUITE 2182
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60604

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADVANCED BIOTHERAPY CONCEPTS INC
		DATE OF NAME CHANGE:	19990524
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
  <head>
    <title>
</title>
</head>
  <body bgcolor="#ffffff" style="MARGIN: 5%; TEXT-INDENT: 0pt">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: -36pt" align="left">&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="white">
            <td width="20%">&#160;<img src="logo1.jpg" alt=""></td>
            <td valign="bottom" width="80%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ADVANCED
              BIOTHERAPY, INC.</font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: -36pt" align="left">&#160;</div>
    <div align="right">
      <table border="0" cellpadding="0" cellspacing="0" width="40%">

          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Administration</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">c/o
                KVG Partners</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">141
                West Jackson Blvd.</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Suite
                2182</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Chicago,
                IL 60604</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Telephone
                312-427-1912</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Fax
                312-427-5396</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="40%" style="border-bottom: #ffffff thin solid;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">www.advancedbiotherapy.com</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 288pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
                21, 2006</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amy
                C. Bruckner</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Staff
                Accountant</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Securities
                &amp; Exchange Commission</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Division
                of Corporation Finance</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington,
                D.C. 20549</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Re:</font><font id="TAB2" style="COLOR: black; LETTER-SPACING: 27pt">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Advanced
                Biotherapy, Inc.</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Item
                4.02(a) Form 8-K Filed December 15, 2006</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">File
                No. 000-26323</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Dear
                Ms. Bruckner:</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">I
                am responding to your letter dated December 15, 2006 regarding the
                Form
                8-K filed December 15, 2006 by Advanced Biotherapy, Inc.
                (&#8220;Company&#8221;).</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">1.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;Please
                tell us whether you have reconsidered, in accordance with Item 307
                of
                Regulation S-B, the adequacy of your previous assertions in your
                Forms
                10-QSB for all of the quarterly periods in Fiscal 2006 and in your
                Form
                10-KSB for the year ended December 31, 2005 regarding your disclosure
                controls and procedures, particularly in light of the restatement
                issues
                that you have described in this 8-K.</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Commission notified the Company that the Company should consider
                its
                accounting for a reduction of the conversion price from $0.25 to
                $0.24 per
                share with respect to its outstanding 2000 and 2002 convertible notes,
                and
                to reclassify certain costs and expenses. The Company recently appointed
                a
                new Chief Financial Officer, Michael G. Bansley, as of October 18,
                2006.
                We believe our new CFO is sufficiently versed in public company accounting
                to address these particular matters.</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc" style="border-bottom: medium none;">&#160;</td>
            <td width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="top" width="80%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Company believes that its internal controls, disclosure controls
                and
                procedures were adequate with respect to the Form 10-KSB, and Forms
                10-QSB
                referenced above but recognizes that its former CFO was unfamiliar
                with
                the technical accounting procedure for reduction in the conversion
                price
                of convertible notes. The Company believes that its internal disclosure
                controls and procedures continue to be adequate with respect to its
                status
                as development stage company and its past and current business regarding
                research and development of its patent portfolio. The Company has
                not
                generated revenue from operations for several years. </font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc" style="border-bottom: medium none;">&#160;</td>
            <td width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="top" width="80%" style="border-bottom: medium none;">&#160;</td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="3">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">my
            C.
            Bruckner</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">December
            21, 2006</font></div>
          <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Page&#160;
            2</font></div>
        </div>
      </div>
    </div>
    <div>&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 72pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
                Company recognizes that the balance of the comments raised by the
                Commission in its letter dated December&#160;1, 2006 relate to
                reclassifications of certain patents and patent pending costs, its
                auction
                rate securities that actually were liquidated after the period in
                question
                and the specific expense regarding vesting of options and warrants
                (non-cash), none of which results in any additional expense to the
                Company
                from such reclassifications. The impact of the additional finance
                charge
                due to the reduction of the conversion price will result in an increase
                in
                our net loss for the year ended December 31, 2005. We will acknowledge
                in
                our amended Form 10-KSB that we have taken steps to improve our internal
                controls and disclosure controls. </font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2.<font id="TAB2" style="LETTER-SPACING: 9pt">&#160;&#160;&#160;</font>&#160;In
                connection with your comments, the Company acknowledged that it is
                responsible for the adequacy and accuracy of the disclosure in the
                filing;
                staff comments or changes to disclosure and response to staff comments
                do
                not foreclose the Commission from taking any action with respect
                to the
                filing; and the Company may not assert staff comments as a defense
                in a
                proceeding initiated by the Commission or any person under the federal
                securities laws of the United States.</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="80%">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 216pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div align="right">
      <table border="0" cellpadding="0" cellspacing="0" width="45%">

          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Very
                truly yours,</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc" style="border-bottom: medium none;">&#160;</td>
            <td width="1%" style="border-bottom: medium none;">&#160;</td>
            <td align="left" valign="top" width="45%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>/s/
                Christopher W. Capps</u></font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Christopher
                W. Capps</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%" style="border-bottom: medium none;">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">President
                and Chief Executive Officer</font></div>
            </td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%">&#160;</td>
          </tr>
          <tr>
            <td width="1%" bgcolor="#6699cc">&#160;</td>
            <td width="1%">&#160;</td>
            <td align="left" valign="top" width="45%">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 216pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div style="WIDTH: 100%; TEXT-ALIGN: center">
      </div>
      <div style="WIDTH: 100%; TEXT-ALIGN: center">
        <hr style="COLOR: black" noshade size="3">
      </div>
    </div>
    <div id="HDR">
      <div id="GLHDR" style="WIDTH: 100%" align="right">
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>filename2.jpg
<TEXT>
begin 644 filename2.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X09_17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P-CHQ,CHR
M,2`Q,SHU-SHS,@```````Z`!``,````!``$``*`"``0````!````,J`#``0`
M```!````,``````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```5)````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`,``R`P$B``(1`0,1`?_=``0`
M!/_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`['Z\?6+#Z-TE]5N5;AY>6US<2VEF]P<(
M]^HV;&_X3_"?Z)<M_BW^N64,ZSZO]:O=;9:]S\3(L=N)>X[GT>H[Z;;I]7'_
M`/,ZUVWUH^KV-]8ND7=/OAMA]^/<1)KM'T+/^^6?\&O"\K"S<7)LZ?D-=3U/
MISCLC0D,]\-?])SJ_P">QG?Z+_K2TN3QX\W+SQ?IG4\7Z$O\GDC_`%/T,BR1
M((+ZQA965]KZX27M#*LTLLW[@XLNN:SV?X+[.S;77_(5)V7FU?4S.L:^W'MK
MRL)K(L)<T/'3G6;;`[Z-WJV6._XU6?\`%]U#I?7^F7.M;'4PRRKJ#=Q]XO=Z
MEF0QOYOVAW[O\U8K'UL'0OJY]5LBJYCK6WV,--3['%UE]8K./NLG?Z5+<6G?
M_P`'6HY3_6^WP2X^.'IK]S_"36EVYW^,SZXV83&]`Z5:YO4<C:;[*C#JV.^A
M4UX^C==_YZ_XQ:/^+WZR4=1P!TW(SK,[JV,US\@V-(]NX,_1W#V7,9NV>HY_
MJV+R*RW-R+W95KG7]4ZF\[`-7_I3M+]OTM]^[T\?;_@O^M+VGZC_`%4J^K?2
M&UO:#GY(#\RP:^[\VEKO]'1N_P"_J7F<./#RL<<AZR;T^:>7],W_`)K'\B`2
M9/1I))+,7O\`_]#U58^?]4^@=1ZI7U7-Q6W9=30UI).T[3N8ZQ@]MCF?RUL)
M(QE*.L28]-#6BGR*K'9]7_\`&M7A=*)HQKK6-?4#[=ES!995M_T;7._1?N*7
MUTK?UK_&3B]&S+''":ZFIC&Z;6V-9;=M_EV._/4^L_\`Y8<;_CL?_P`]L2ZQ
M_P#EAQ_^.QO_`#TQ;,9#W,<O\I]TX^+]+C_>8^A_O/>T_4WZNX_5Z^L48C:L
MNENUFTD,X],/]+Z'J,9[6N6VDDL>4Y2KBD94*%F]&12222:I_]'U5))))3Y/
MU@Q_CAQO^.Q__/3$NL?_`)8<?_CL;_STQ=[D?4_HF1UUG7[6//4*W,>UP>0V
M:QL9^C^C]$)LGZF]%R>O,^L%K;/M];F/:X/(;-8#&>S^JU7H\WC$HFI>G!['
M3Y_^]6\)_&W<2225%<I))))3_]G_[0LZ4&AO=&]S:&]P(#,N,``X0DE-!"4`
M`````!``````````````````````.$))30/M```````0`$@````!``$`2```
M``$``3A"24T$)@``````#@`````````````_@```.$))300-```````$````
M>#A"24T$&0``````!````!XX0DE-`_,```````D```````````$`.$))300*
M```````!```X0DE-)Q````````H``0`````````".$))30/U``````!(`"]F
M9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&
M```````!`#4````!`"T````&```````!.$))30/X``````!P``#_________
M____________________`^@`````_____________________________P/H
M`````/____________________________\#Z`````#_________________
M____________`^@``#A"24T$`````````@`!.$))300"```````$`````#A"
M24T$"```````$`````$```)````"0``````X0DE-!!X```````0`````.$))
M300:``````-)````!@``````````````,````#(````*`%4`;@!T`&D`=`!L
M`&4`9``M`#$````!``````````````````````````$``````````````#(`
M```P``````````````````````$`````````````````````````$`````$`
M``````!N=6QL`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M```P`````%)G:'1L;VYG````,@````9S;&EC97-6;$QS`````4]B:F,````!
M```````%<VQI8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$
M;&]N9P`````````&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T
M;T=E;F5R871E9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R``
M```&8F]U;F1S3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``
M````````3&5F=&QO;F<``````````$)T;VUL;VYG````,`````!29VAT;&]N
M9P```#(````#=7)L5$585`````$```````!N=6QL5$585`````$```````!-
M<V=E5$585`````$```````9A;'1486=415A4`````0``````#F-E;&Q497AT
M27-(5$U,8F]O;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG
M;F5N=6T````/15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L
M:6=N96YU;0````]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O
M;&]R5'EP965N=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET
M;W!/=71S971L;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T
M=&]M3W5T<V5T;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-
M!"@```````P````!/_`````````X0DE-!!0```````0````".$))300,````
M``5E`````0```#(````P````F```'(````5)`!@``?_8_^``$$I&248``0(!
M`$@`2```_^T`#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,"`@(
M"0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1
M#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``P`#(#
M`2(``A$!`Q$!_]T`!``$_\0!/P```04!`0$!`0$``````````P`!`@0%!@<(
M"0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(
M!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/P
MX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6U
MQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U
M`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086
MHK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#L?KQ]8L/HW27U
M6Y5N'EY;7-Q+:6;W!PCWZC9L;_A/\)_HERW^+?ZY90SK/J_UJ]UMEKW/Q,BQ
MVXE[CN?1ZCOIMNGU<?\`\SK7;?6CZO8WUBZ1=T^^&V'WX]Q$FNT?0L_[Y9_P
M:\+RL+-Q<FSI^0UU/4^G..R-"0SWPU_TG.K_`)[&=_HO^M+2Y/'CS<O/%^F=
M3Q?H2_R>2/\`4_0R+)$@@OK&%E97VOKA)>T,JS2RS?N#BRZYK/9_@OL[-M=?
M\A4G9>;5]3,ZQK[<>VO*PFLBPES0\=.=9ML#OHW>K98[_C59_P`7W4.E]?Z9
M<ZUL=3#+*NH-W'WB]WJ69#&_F_:'?N_S5BL?6P="^KGU6R*KF.M;?8PTU/L<
M767UBLX^ZR=_I4MQ:=__``=:CE/];[?!+CXX>FOW/\)-:7;G?XS/KC9A,;T#
MI5KF]1R-IOLJ,.K8[Z%37CZ-UW_GK_C%H_XO?K)1U'`'3<C.LSNK8S7/R#8T
MCV[@S]'</9<QF[9ZCG^K8O(K+<W(O=E6N=?U3J;SL`U?^E.TOV_2WW[O3Q]O
M^"_ZTO:?J/\`52KZM](;6]H.?D@/S+!K[OS:6N_T=&[_`+^I>9PX\/*QQR'K
M)O3YIY?TS?\`FL?R(!)D]&DDDLQ>_P#_T/55CY_U3Z!U'JE?5<W%;=EU-#6D
MD[3M.YCK&#VV.9_+6PDC&4HZQ)CTT-:*?(JL=GU?_P`:U>%THFC&NM8U]0/M
MV7,%EE6W_1M<[]%^XI?72M_6O\9.+T;,L<<)KJ:F,;IM;8UEMVW^78[\]3ZS
M_P#EAQO^.Q__`#VQ+K'_`.6''_X[&_\`/3%LQD/<QR_RGW3CXOTN/]YCZ'^\
M][3]3?J[C]7KZQ1B-JRZ6[6;20SCTP_TOH>HQGM:Y;:22QY3E*N*1E0H6;T9
M%))))JG_T?54DDDE/D_6#'^.'&_X['_\],2ZQ_\`EAQ_^.QO_/3%WN1]3^B9
M'76=?M8\]0K<Q[7!Y#9K&QGZ/Z/T0FR?J;T7)Z\SZP6ML^WUN8]K@\ALU@,9
M[/ZK5>CS>,2B:EZ<'L=/G_[U;PG\;=Q)))45RDDDDE/_V0`X0DE-!"$`````
M`%,````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````2
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``0P!3`````0`X0DE-
M!`8```````<`"`````$!`/_A%_AH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q
M+C`O`#P_>'!A8VME="!B96=I;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53
M>DY48WIK8SED)S\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TG861O8F4Z;G,Z;65T
M82\G('@Z>&UP=&L])UA-4"!T;V]L:VET(#,N,"TR."P@9G)A;65W;W)K(#$N
M-B<^"CQR9&8Z4D1&('AM;&YS.G)D9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY
M.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA
M9&]B92YC;VTO:5@O,2XP+R<^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70])W5U:60Z,&(S,V$R9F4M.3$R-2TQ,61B+6$V8C<M.31F.#%D-#9C8S$S
M)PH@('AM;&YS.F5X:68])VAT='`Z+R]N<RYA9&]B92YC;VTO97AI9B\Q+C`O
M)SX*("`\97AI9CI#;VQO<E-P86-E/C$\+V5X:68Z0V]L;W)3<&%C93X*("`\
M97AI9CI0:7AE;%A$:6UE;G-I;VX^-3`\+V5X:68Z4&EX96Q81&EM96YS:6]N
M/@H@(#QE>&EF.E!I>&5L641I;65N<VEO;CXT.#PO97AI9CI0:7AE;%E$:6UE
M;G-I;VX^"B`\+W)D9CI$97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TG=75I9#HP8C,S83)F92TY,3(U+3$Q9&(M839B-RTY-&8X
M,60T-F-C,3,G"B`@>&UL;G,Z<&1F/2=H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O)SX*(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2=U=6ED.C!B,S-A,F9E+3DQ,C4M,3%D8BUA-F(W+3DT
M9C@Q9#0V8V,Q,R<*("!X;6QN<SIP:&]T;W-H;W`])VAT='`Z+R]N<RYA9&]B
M92YC;VTO<&AO=&]S:&]P+S$N,"\G/@H@(#QP:&]T;W-H;W`Z2&ES=&]R>3X\
M+W!H;W1O<VAO<#I(:7-T;W)Y/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z,&(S,V$R9F4M.3$R-2TQ
M,61B+6$V8C<M.31F.#%D-#9C8S$S)PH@('AM;&YS.G1I9F8])VAT='`Z+R]N
M<RYA9&]B92YC;VTO=&EF9B\Q+C`O)SX*("`\=&EF9CI/<FEE;G1A=&EO;CXQ
M/"]T:69F.D]R:65N=&%T:6]N/@H@(#QT:69F.EA297-O;'5T:6]N/C<R+S$\
M+W1I9F8Z6%)E<V]L=71I;VX^"B`@/'1I9F8Z65)E<V]L=71I;VX^-S(O,3PO
M=&EF9CI94F5S;VQU=&EO;CX*("`\=&EF9CI297-O;'5T:6]N56YI=#XR/"]T
M:69F.E)E<V]L=71I;VY5;FET/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z,&(S,V$R9F4M.3$R-2TQ
M,61B+6$V8C<M.31F.#%D-#9C8S$S)PH@('AM;&YS.GAA<#TG:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87`O,2XP+R<^"B`@/'AA<#I#<F5A=&5$871E/C(P,#8M
M,3(M,C%4,3,Z-3<Z,S(M,#4Z,#`\+WAA<#I#<F5A=&5$871E/@H@(#QX87`Z
M36]D:69Y1&%T93XR,#`V+3$R+3(Q5#$S.C4W.C,R+3`U.C`P/"]X87`Z36]D
M:69Y1&%T93X*("`\>&%P.DUE=&%D871A1&%T93XR,#`V+3$R+3(Q5#$S.C4W
M.C,R+3`U.C`P/"]X87`Z365T861A=&%$871E/@H@(#QX87`Z0W)E871O<E1O
M;VP^061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,\+WAA<#I#<F5A=&]R5&]O
M;#X*(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2=U=6ED.C!B,S-A,F9E+3DQ,C4M,3%D8BUA-F(W+3DT9C@Q9#0V
M8V,Q,R<*("!X;6QN<SIX87!-33TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+VUM+R<^"B`@/'AA<$U-.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO
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M"CPO>#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*/#]X<&%C:V5T(&5N9#TG=R<_/O_B#%A)0T-?4%)/
M1DE,10`!`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C
M<W!-4T94`````$E%0R!S4D="``````````````````#VU@`!`````-,M2%`@
M(```````````````````````````````````````````````````````````
M````$6-P<G0```%0````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0`
M``($````%')865H```(8````%&=865H```(L````%&)865H```)`````%&1M
M;F0```)4````<&1M9&0```+$````B'9U960```-,````AG9I97<```/4````
M)&QU;6D```/X````%&UE87,```0,````)'1E8V@```0P````#')44D,```0\
M```(#&=44D,```0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT
M("AC*2`Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C````````
M`!)S4D="($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M
M,BXQ````````````````````````````````````````````````````````
M``````````!865H@````````\U$``0````$6S%A96B``````````````````
M````6%E:(````````&^B```X]0```Y!865H@````````8ID``+>%```8VEA9
M6B`````````DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N
M:65C+F-H```````````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````
M`````````````````````````````````````````````````````&1E<V,`
M````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@``````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@````````````````````````````!D97-C
M`````````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y
M-C8M,BXQ```````````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N
M(&EN($E%0S8Q.38V+3(N,0``````````````````````````````````=FEE
M=P``````$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6
M`%````!7'^=M96%S``````````$````````````````````````"CP````)S
M:6<@`````$-25"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R
M`#<`.P!``$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`
MI`"I`*X`L@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9
M`1\!)0$K`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!
MN0'!`<D!T0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z
M`H0"C@*8`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#
M<@-^`XH#E@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,
M!)H$J`2V!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%
MY07V!@8&%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A
M!W0'A@>9!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`)
M)0DZ"4\)9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+
M"R(+.0M1"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-
M0`U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6
M#[,/SP_L$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B82
M11)D$H02HQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42
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M-8<UPC7]-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0Z
MLCKO.RT[:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C
M0&1`ID#G02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&
M(D9G1JM&\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ
M3'),NDT"34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2
MQU,34U]3JE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI
M6;A:!UI66J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@
MJF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I
M:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAO
MT7`K<(9PX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S
M>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`
M1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.
MB3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2
M$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"
MFZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E
M.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6
MKXNP`+!UL.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JY
MPKH[NK6[+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11
MQ,[%2\7(QD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/
MN-`YT+K1/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[
MVX#<!=R*W1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G
M'^>IZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9
M\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW_
M___N``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!
M`0$!`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`__``!$(`#``,@,!$0`"$0$#$0'_W0`$``?_Q`&B
M````!@(#`0`````````````'"`8%!`D#"@(!``L!```&`P$!`0``````````
M``8%!`,'`@@!"0`*"Q```@$#!`$#`P(#`P,"!@EU`0(#!!$%$@8A!Q,B``@Q
M%$$R(Q4)44(6820S%U)Q@1ABD25#H;'P)C1R"AG!T34GX5,V@O&2HD14<T5&
M-T=C*%565QJRPM+B\F2#=).$9:.SP]/C*3AF\W4J.3I(24I865IG:&EJ=G=X
M>7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76U]C9VN3E
MYN?HZ>KT]?;W^/GZ$0`"`0,"!`0#!00$!`8&!6T!`@,1!"$2!3$&`"(305$'
M,F$4<0A"@2.1%5*A8A8S";$DP=%#<O`7X8(T)9)3&&-$\:*R)C495#9%9"<*
M<X.31G3"TN+R565U5C>$A:.SP]/C\RD:E*2TQ-3D])6EM<75Y?4H1U=F.':&
MEJ:VQM;F]F=WAY>GM\?7Y_=(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*
M6FIZBIJJNLK:ZOK_V@`,`P$``A$#$0`_`-E'^>'_`##>G_@_\3-T;5W3WYVC
M\>^[N^-L[EV]\?M[=2]>5.]]SXG=>&&.GJ,]++6X]MMX_;F(FK::/+D5D.:&
M/JY'Q:/6"(KD']WCVZYBYNYL_K3MO*-CONP[`RW-[97#HS7,7=6&&U\19)YW
M4.UL'4VK3QHEP61O"D*MVNXH(/`>X:*67"L*X/J6I0`8K^*AJ/44(?\`";[^
M<AVA1]X;R_EO?.SL_,[SW9O;>.X-T?'OMS?VZ)]PY#*;ZW#7MG,]U@^ZLG)+
M-N3!=DMD'W!M&M\KQSR3S00/+%6X^*+([[W/M/R9NG)O+?OU[5QVHY:FAMH9
MTMH_"A,#((K6X6,E!"8M$5G);K"DB,4#HC1RT*-AOKA+B;:[XMXP)(J:FO%A
M7-:Y8&M.-#D=6;]*=F=G#M?^:K63U&[\7#MOJO\`F*5VUMVR[\FW/0;FRNPO
MDQV[B-LSR;?F%8VQLIU)@8:+$X>&:2+[G%S?L1-3TZ^(&\Z;7LLFV_=ZM4NH
M96>;EQ9+81&)K9;G:MODE*2!E$BW\FN:?PUK'-$'=EDGK)NQDG\;?F=F*AI=
M)(H*`_#P[M)J0U2.XI^"@+/7=M]S;2_DS_*;<>*W3VAU9O#:GRJ_EV83;HI.
MVMQ9O<^U<+O?%?RW,INV/";UQV?J:VCQ'9M9OG,9>NI(:F/RON"K2JC$TU0I
MUO5MMNX?>%B$T]KNEK-L?,^J1[5%CD,47,D<0,$L8`>U6**&)M/Z9MXWA8!(
MV#L(,6U.R(8W,T!-#FI\"I)'&HX^HP?3KK_A3%_.$W#T/A,)_+L^(&^]PXCY
M3=KS;9J^U-W=>9IL1N3JW8^=JHSMG8V+W#CYHLA@>P^SJEH9&^WFIJR@P961
MF1<C3N5GW-?9';.:]QW#W6YVCM6Y-V=G6.*X"&.6=8];S2AV"+!:HP?5(IC:
M7@08'I[F'<G@1+&V+?42<2.(%>`IYM\LT^T='+_X3X_S(-D_)WH:F^+G8GRK
M[`^2WS7Z9PVX]U=QY#?>RZVDCIMM0;JQVW((-I]E8VAJ]N]E;9VO7Y>CQZ9B
MNRDF<S,\DM8(11M%XH[^\C[=7EM?I[N\M<DV6T^TN\S1Q[>;=EC\56CD:&X>
MT8H]O]=#"]W%''!''%`T:3*ER7UJ]GNU*_037+27\8)>N:9%1J\]).DDDDFM
M,4ZV+?>+/1WU_]#;N_F??R]^M/YE_P`1.P_C9OM<=B-R5M,=S=.]BU6/2NK>
MKNV<-3U!VMNNE`7[IL74--)CLQ3PLDE;A:VJ@1XY'21)3]FO=/=_9WG_`&CG
M3:X_%ACK%<P$E1<6LA'C1$@BC"BRPEM2)<1Q.Z2*I1D6X64>X6LENYH3E3Z,
M.!_R'Y$C''KY1O9G37<_4G8F]?C9V7B,WL+Y=?$#<5:=JR8JIBH\WE<+LJK.
MZJO'8O/*])E<IE=HT*0;GV57T[DSX(3PP!B,7".PNU;)R9S5R_O5_!N+7WLU
MSJB$6[^(BV=W=,$;Z9-(^G2\N6:6:I$D>Z.)%J9V,<>F>5)(PM!?VS$:@0=0
M0D$,:Y*4TT_A!!^'._/_`,)]^_?BY_,9^,O9&2W9C):7Y@TVT^U^KOE]A#O#
M-)-V#B/D/NR?>.\.XMOXG[Z)<1B^V\Y3O/4?8)%'@LM%44E/XJ<TQEYG>_?+
M7NK[/<T[7LV[;U)=<NVTEC)MEX;:WC5QML`M[,,%1AXMK$/#9'9O%`$L@=FP
M--KFL=P@>2.,+*P8.M2?C-6_)CFHX<!T,G\V*D^"O\L'^5IVYM/>F`W5OB@[
M2W[UWD>M>OMV=I;[RN[>V._^L*/KNNZ?BRVZ_P")5&XL=L3KK$]%;=.12F:F
MI%P^%6F)^YK%:8.>UEK[L^\7N;MHY;O57?([:>*:[6VMEBM;*\::&\EDB2)(
MG:3Z^X)[3/(\K.K!E\1'KTV.WV3F9?TM0(74:LRT*@&I.-`^0`H?0_.GSNYN
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M-4[(2:2W&A&;"D1I%&5!CZ&VR[>=OM-,J`73FKT.KS.D5H.`XC(#$T+#)N<]
MX_=&_7__T=_CW[KW5='?/\I_X%?)SY0;,^7_`'ET)@-_]T[&P&'P.,R.3K,E
M3[=RO]VLQ'FMK9K=NU\?54>*W?GMLS1^"CJ,BE0%HM-/(DD,<21R-LONY[D\
MO<HWW(FR\X7=ORG<,Y>W4KI_4%'".5,D:OQ9(W168EB"S$E))86<LZW4ENIG
M'`_9P^1_/K3#VQU_B_Y;G_"JO9_1GQ&K\QUGU%V)VIU]@-P[`HJTOMB?9'?'
M76+W9NSKX8D*E++L_!YW.--A*:<3-BY*.DDB<24\97H_>37'N_\`<DFYK]PX
MH;S?;7;[J:WN`#XRR6$\MO',[M4^-*(6$[*0LJNU0"Q`""@6',@@M"5B9U!'
ME1@"1]@KCTZ>OYSF"S'SK_X4C="?!ON_>>Y:CX_8?<?Q]ZZV]M?!U,6-?;6U
MNSMF[0[![-.$D$;Q4VX]Z9.H:&HR;I)4+!#2)ZDHX$6GW?8K?VO^Z+S![I<L
MV-N.;KJTOKJ22168.]G<7-O;K(-8U)$J,RJI109')4LSL_MU)O=^BLIF/@*R
MJ`/+4%)ICB?SX=;?NSOY./\`+LZZ^6NROFMU]\>,!LKO#8&`GP>W9=O9'+TF
MQJ>H.!&U<=N8]?R5D^UXMV8';)>BH:Z"GA>*-Q(P>>*GEAYW3^]7NE=<H[MR
M)=<XW,O*E](SS0.L3:V:99VI*T9F16E0,4CD52"RE=#NK"N/:[&*6&9(/U8U
M`4DL30#2*U)U&GFU2>)-<]6>>XNZ7]>]^Z]U_]+?X]^Z]U[W[KW7SYOF.C2?
M\+`^D$5RG_&8_BHY(%[K#TKM28I]1Q)X])_U_P`_3WTYM-TGVG^[RMIH"U94
MN(&H=)*S[Y<1-FA-*/4C\0!0D!CT#&02<V$'R(/[(@>L?S#<O_PL)Z>!O^WW
M/\3$N3>X_P!!&Q''^L`'M;_#W[V?O3=?<2]Q82E#;Q[O'6M=57\6O`4IXFFF
M?AK7-!;<ET\SV9'GX9_E3_)U]!WWS&Z&/7O?NO=>]^Z]U__3W^/?NO=>]^Z]
MU\^#YA2K#_PL'Z8=@2#W3\5(AIL3JFZ+V?"AY(X#2"_^'OHMM5I)>_W?VZPQ
M,H87SR9K2D6Y)*PP#DJA`\JTJ0,@).P7FI"?X0/VI3KWS"4C_A83U`2+!^Z?
MB8R_3D#H?8:W_P`/4I]GGLS;S0_<5]SI)4HDW[V=#4&JC1&3@X[T84-#BM*$
M$TW,@\SV0'$"+_!7_+U]!_WS-Z&'7O?NO=>]^Z]U_]3?X]^Z]U[W[KW57G8'
M\G[X4=F?.O;W\QG=.U]]S_)S:^?V-N;$YRC[$W!1;4CRW7>"H-N;:EFV=%)_
M"IHHL7C8EFC(T3."S"Y/N18_=GW%AY$;VRBYIG7D4@@V@6,)0S-<,->CQ=+3
M,79?$HQ-&!6@Z2&PM#=?6&`?4_Q9]*>M.&.'4#L;^3A\+.T_GCMW^8YNK$=E
MGY+[8W-U[NW%Y3%=D9C%;0&7ZRP>(V]M@U&U:6):>>B_AF$@2KIS*(JL:Q("
MLCJ7=H]W_<?8N2+_`-N-JYFDBY*N5F$EKX<#JPN"3*`[Q-*NLDGL==))*T)K
FUJ2PM);E+R2$&Y6E&J1\/#`-,?9U:E[C7I9U[W[KW7O?NO=?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
